Vaccination

The CDC’s Advisory Committee on Immunization Practices unanimously voted to recommend respiratory syncytial virus vaccinations for all adults aged 75 years and older, as well as those aged 60 to 74 years at high risk for severe disease.

As a past president of the Pennsylvania Optometric Association, I am very familiar with how our profession expands its scope of practice.

After decades of RSV vaccine development, the approvals and recommendations were seen as landmark events in preventive medicine. Uptake was low, however — not unusual for first-year approvals, experts told Healio.

Healio has compiled June’s most-read news in asthma and allergy.

Avian influenza continues to be detected among birds and dairy cows in the United States, raising questions about how to control the more than 2-year-old outbreak.

A panel of experts agreed that vaccines can be safe and effective in patients receiving dupilumab, although they said that physicians should engage with patients in decision-making before vaccination.

Hypersensitivity to polyethylene glycols is not a common cause of anaphylaxis induced by drugs, according to a study published in Annals of Allergy, Asthma & Immunology.

The CDC’s vaccine advisors voted unanimously Wednesday to recommend that everyone aged 75 years or older get vaccinated against respiratory syncytial virus.

The FDA has approved Capvaxive, Merck’s 21-valent pneumococcal vaccine, which is specifically made to protect adults.

Together, a group of viruses nicknamed “FLiRT” have emerged to become the most common SARS-CoV-2 variants in the country.